Mario Polywka
Chief Executive Officer at EVOTEC SE
Net worth: 542 335 $ as of 2024-03-30
Profile
Mario Eugenio Cosimino Polywka is currently the Chief Executive Officer & Member-Supervisory Board at Evotec SE since 2024.
He is also the Director at Evotec (India) Pvt Ltd.
since 2009, the Non-Executive Director at Orbit Discovery Ltd.
since 2019, the Director at Forge Therapeutics, Inc. since 2017, and the Independent Director at Exscientia Plc since 2017.
Mario has previously held positions such as Chief Executive Officer at Oxford Asymmetry International Plc from 2001 to 2002, Non-Executive Chairman at Nanotether Discovery Science Ltd.
from 2014 to 2015, and Non-Executive Chairman at GlycoForm Ltd.
from 2004 to 2011.
He has also served as the Chief Operating Officer at Evotec SE from 2014 to 2018.
Mario's education includes an undergraduate degree from the University of Oxford, a doctorate degree from the University of Oxford in 1988, and an undergraduate degree from Hertford College in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXSCIENTIA PLC
0.05% | 2024-02-29 | 62,198 ( 0.05% ) | 355 773 $ | 2024-03-30 |
EVOTEC SE
0.01% | 2022-12-30 | 11,938 ( 0.01% ) | 186 562 $ | 2024-03-30 |
Mario Polywka active positions
| Companies | Position | Start |
|---|---|---|
| EVOTEC SE | Chief Executive Officer | 2024-01-02 |
| EXSCIENTIA PLC | Director/Board Member | 2017-09-27 |
Blacksmith Medicines, Inc.
 Blacksmith Medicines, Inc. Pharmaceuticals: MajorHealth Technology Blacksmith Medicines, Inc. is a pharmaceutical company based in San Diego, CA and has subsidiaries in the United States. Blacksmith Medicines is focused on developing medicines that target metal-dependent enzymes found in human physiology. The company's platform combines a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzymes active site. The company recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes. The company was founded by Zachary A. Zimmerman and has been led by him as the CEO since incorporation. | Director/Board Member | - |
Orbit Discovery Ltd.
 Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 2019-08-31 |
Forge Therapeutics, Inc.
 Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | Director/Board Member | 2017-05-15 |
Evotec (India) Pvt Ltd.
 Evotec (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Research Support International Pvt Ltd. provides drug discovery & development services. Its facilities include analytical, synthetic, kilo, hydrogenation, humidity control and hazardous reactions labs. The company is headquartered in Thane, India. | Director/Board Member | 2009-08-30 |
Former positions of Mario Polywka
| Companies | Position | End |
|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Director/Board Member | 2024-01-17 |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | Director/Board Member | 2018-12-31 |
| EVOTEC SE | Chief Operating Officer | 2018-12-30 |
| ░░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of Mario Polywka
| University of Oxford | Doctorate Degree |
| Hertford College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| EVOTEC SE | Health Technology |
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| EXSCIENTIA PLC | Health Technology |
| Private companies | 15 |
|---|---|
Cyprotex Discovery Ltd.
 Cyprotex Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex Discovery Ltd. is a British company that specializes in in vitro toxicology studies using a range of techniques such as cell-based assays, mass spectrometer, fluorescence imaging, and qrt-pcr endpoints. The private company is based in Abingdon, UK. The company also offers mitochondrial toxicity assays including seahorse assay, glu/gal assay, mitochondrial biogenesis, mitochondrial membrane potential, and mitochondrial mass. | Commercial Services |
| Oxford Asymmetry International Plc | Process Industries |
Pharminox Ltd
 Pharminox Ltd Medical/Nursing ServicesHealth Services Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown. | Health Services |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Commercial Services |
Evotec (München) GmbH
 Evotec (München) GmbH Chemicals: Major DiversifiedProcess Industries Part of Evotec SE, Evotec (München) GmbH is a German company that provides manufacturing and research support services for pharmaceutical and biotechnology companies. The company is based in Neuried, Germany. The CEOs are Dirk Ullmann, Loëtitia Edith Rouxel. The private company was founded in 2005 by Axel Ullrich, Hellmut Kirchner, Henrik Daub. Evotec (München was acquired by Evotec SE on April 19, 2011 for $20.40 million. | Process Industries |
Evotec (India) Pvt Ltd.
Evotec (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Research Support International Pvt Ltd. provides drug discovery & development services. Its facilities include analytical, synthetic, kilo, hydrogenation, humidity control and hazardous reactions labs. The company is headquartered in Thane, India. | Health Technology |
Nanotether Discovery Science Ltd.
 Nanotether Discovery Science Ltd. Pharmaceuticals: MajorHealth Technology Nanotether Discovery Science Ltd. engages in the discovery of new medicines by accelerating the progression of potential drug candidates. The company was founded by Trevor Dale, Adrian Harwood and Paola Borri in 2012 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Aptuit (Oxford) Ltd.
 Aptuit (Oxford) Ltd. Pharmaceuticals: MajorHealth Technology Part of Evotec SE, Aptuit (Oxford) Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in Abingdon, UK. | Health Technology |
Orbit Discovery Ltd.
Orbit Discovery Ltd. Pharmaceuticals: MajorHealth Technology Orbit Discovery Ltd. develops technology for discovery process and drug development. The company was founded by Terry Rabbitts and Graham Ogg and is headquartered in Oxford, the United Kingdom. | Health Technology |
Forge Therapeutics, Inc.
Forge Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Forge Therapeutics, Inc. manufactures pharmaceutical products. It is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry to target metalloproteins. The company was founded by Zachary A. Zimmerman, Seth Cohen and David Puerta and is headquartered in San Diego, CA. | Health Technology |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Blacksmith Medicines, Inc.
Blacksmith Medicines, Inc. Pharmaceuticals: MajorHealth Technology Blacksmith Medicines, Inc. is a pharmaceutical company based in San Diego, CA and has subsidiaries in the United States. Blacksmith Medicines is focused on developing medicines that target metal-dependent enzymes found in human physiology. The company's platform combines a focused library of metal-binding pharmacophores with proprietary computational modeling approaches to rapidly and rationally design small molecule inhibitors that interact with key metal ions in the enzymes active site. The company recognized a large unmet need for new chemical matter and innovative approaches to drug this important class of enzymes. The company was founded by Zachary A. Zimmerman and has been led by him as the CEO since incorporation. | Health Technology |
| Activotec SPP Ltd. | |
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | Commercial Services |
- Stock Market
- Insiders
- Mario Polywka
